{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T08:50:43Z","timestamp":1767084643114,"version":"3.40.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ajp.2024.104005","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T11:30:49Z","timestamp":1710156649000},"page":"104005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Role of adjunctive cariprazine for treatment-resistant depression in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"95","author":[{"given":"Eman","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fakhar","family":"Latif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusra","family":"Mashkoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabia","family":"Owais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadiq","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Moeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-9380","authenticated-orcid":false,"given":"Sanila","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2024.104005_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fendo.2020.00195","article-title":"Immunoendocrine peripheral effects induced by atypical antipsychotics","volume":"11","author":"Alvarez-Herrera","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ajp.2024.104005_bib2","unstructured":"Bains, N., Abdijadid, S., 2023. Major {Depressive} {Disorder}, in: StatPearls. StatPearls Publishing, Treasure Island (FL)."},{"key":"10.1016\/j.ajp.2024.104005_bib3","first-page":"252","article-title":"The therapeutic role of 5-{HT1A} and 5-{HT2A} receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"J. Psychiatry \\ Neurosci. JPN"},{"key":"10.1016\/j.ajp.2024.104005_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103480","article-title":"Taiwan consensus on biological treatment of bipolar disorder during the acute, maintenance, and mixed phases: {The} 2022 update","volume":"82","author":"Cheng","year":"2023","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2024.104005_bib5","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2147\/NDT.S159704","article-title":"Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy","volume":"14","author":"Citrome","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ajp.2024.104005_bib6","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2147\/NDT.S113099","article-title":"Antipsychotic-associated weight gain: management strategies and impact on treatment adherence","volume":"13","author":"Dayabandara","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ajp.2024.104005_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4088\/JCP.15m10070","article-title":"Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder","volume":"77","author":"Durgam","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104005_bib8","first-page":"62","article-title":"Cariprazine {Augmentation} to {Antidepressant} {Therapy} in {Major} {Depressive} {Disorder}: {Results} of a {Randomized}, {Double}-{Blind}, {Placebo}-{Controlled} {Trial}","volume":"48","author":"Earley","year":"2018","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.ajp.2024.104005_bib9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S1461145710000015","article-title":"Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study","volume":"13","author":"El-Khalili","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2024.104005_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/YIC.0000000000000235","article-title":"Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial","volume":"33","author":"Fava","year":"2018","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2024.104005_bib11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ajp.2024.104005_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1176\/appi.ajp.20230025","article-title":"Pharmacotherapies for treatment-resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape","volume":"180","author":"Jha","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104005_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.31887\/DCNS.2015.17.3\/akaczkurkin","article-title":"Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence","volume":"17","author":"Kaczkurkin","year":"2015","journal-title":"Dialog-. Clin. Neurosci."},{"year":"2019","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","key":"10.1016\/j.ajp.2024.104005_bib14"},{"key":"10.1016\/j.ajp.2024.104005_bib15","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1080\/03007995.2018.1519317","article-title":"Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorder","volume":"34","author":"Kamijima","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ajp.2024.104005_bib16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40263-016-0382-z","article-title":"Tolerability and safety profile of cariprazine in treating psychotic disorders, bipolar disorder and major depressive disorder: a systematic review with meta-analysis of randomized controlled trials","volume":"30","author":"Lao","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2024.104005_bib17","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1007\/s12325-021-01797-5","article-title":"Cariprazine, {A} {Broad}-{Spectrum} {Antipsychotic} for the {Treatment} of {Schizophrenia}: {Pharmacology}, {Efficacy}, and {Safety}","volume":"38","author":"Laszlovszky","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ajp.2024.104005_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jad.2020.08.012","article-title":"What are the emotions underlying feeling fat and fear of weight gain?","volume":"277","author":"Levinson","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ajp.2024.104005_bib19","article-title":"Summary of the comparative effectiveness review on off-label use of atypical antipsychotics","volume":"18","author":"Maher","year":"2012","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.ajp.2024.104005_bib20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-147-9-200711060-00003","article-title":"Risperidone for treatment-refractory major depressive disorder: a randomized trial","volume":"147","author":"Mahmoud","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ajp.2024.104005_bib21","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s40265-015-0494-7","article-title":"Cariprazine: {First} {Global} {Approval}","volume":"75","author":"McCormack","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ajp.2024.104005_bib22","first-page":"3","article-title":"Atypical antipsychotics: sleep, sedation, and efficacy","volume":"6","author":"Miller","year":"2004","journal-title":"Prim. Care Comp. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104005_bib23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/jcph.2022","article-title":"Efficacy and safety of adjunctive serotonin-dopamine activity modulators in major depression: a meta-analysis of randomized controlled trials","volume":"62","author":"Mishra","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ajp.2024.104005_bib24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials","volume":"166","author":"Nelson","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104005_bib25","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ajp.2024.104005_bib26","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The {PRISMA} 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajp.2024.104005_bib27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4088\/JCP.v68n0602","article-title":"Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis","volume":"68","author":"Papakostas","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104005_bib28","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.OT19037BR3","article-title":"Inadequate response to treatment in major depressive disorder: augmentation and adjunctive strategies","volume":"81","author":"Rafeyan","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104005_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/da.23135","article-title":"Treatment-resistant major depressive disorder: {Canadian} expert consensus on definition and assessment","volume":"38","author":"Rybak","year":"2021","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.ajp.2024.104005_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1176\/appi.ajp.20220504","article-title":"Adjunctive {Cariprazine} for the {Treatment} of {Patients} {With} {Major} {Depressive} {Disorder}: {A} {Randomized}, {Double}-{Blind}, {Placebo}-{Controlled} {Phase} 3 {Study}","volume":"180","author":"Sachs","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104005_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ajp.2024.104005_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103720","article-title":"Ketamine versus electroconvulsive therapy for treatment-resistant depression: {An} updated meta-analysis of randomized clinical trials","volume":"88","author":"Shafiee","year":"2023","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2024.104005_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001403","article-title":"Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes","volume":"10","author":"Spielmans","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.ajp.2024.104005_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1092852916000043","article-title":"Mechanism of action of cariprazine","volume":"21","author":"Stahl","year":"2016","journal-title":"CNS Spectr."},{"key":"10.1016\/j.ajp.2024.104005_bib35","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajp.2024.104005_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.ajp.2024.104005_bib37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4088\/JCP.v68n0207","article-title":"A randomized, double-blind comparison of olanzapine\/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder","volume":"68","author":"Thase","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2024.104005_bib38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/YIC.0000000000000246","article-title":"Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder","volume":"34","author":"Vieta","year":"2019","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2024.104005_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/NDT.S198774","article-title":"Management of {Treatment}-{Resistant} {Depression}: {Challenges} and {Strategies}","volume":"16","author":"Voineskos","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ajp.2024.104005_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/phar.1204","article-title":"Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature","volume":"33","author":"Wright","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ajp.2024.104005_bib41","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1017\/S0033291722001246","article-title":"Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis","volume":"52","author":"Yan","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ajp.2024.104005_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv060","article-title":"Atypical antipsychotic augmentation for treatment-resistant depression: a systematic review and network meta-analysis","volume":"18","author":"Zhou","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201824000984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201824000984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T14:16:11Z","timestamp":1715264171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201824000984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":42,"alternative-id":["S1876201824000984"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2024.104005","relation":{},"ISSN":["1876-2018"],"issn-type":[{"type":"print","value":"1876-2018"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of adjunctive cariprazine for treatment-resistant depression in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2024.104005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104005"}}